Iracema Nayach

1.2k citations
12 papers · 915 indexed · h-index 10
Topics
Lymphoma Diagnosis and Treatment (7 papers)Cancer-related Molecular Pathways (4 papers)RNA modifications and cancer (3 papers)
Partner nations
SpainNetherlandsFrance

In The Last Decade

Iracema Nayach

12 papers receiving 895 citations

Peers

Iracema Nayach
Comparison fields: 5 of 57
  • Oncology 544
  • Pathology and Forensic Medicine 438
  • Molecular Biology 394
  • Genetics 222
  • Pulmonary and Respiratory Medicine 111
Replace Carsten Schwäenen with:
Carsten Schwäenen Germany
Maite Cazorla Spain
María Rodríguez‐Pinilla Spain
Christopher D. Carey United States
Maciej Giefing Poland
Oday Hamid United States
Hideyuki Abe Japan
Mikel Lipschitz United States
Lisa H. Butler United Kingdom
Margaretha G.M. Roemer United States
Iracema Nayach relative to Carsten Schwäenen Germany Carsten Schwäenen's profile →
Citations per field
00.5×1.5×
Carsten Schwäenen · 1×
Citations per year

Countries citing papers authored by Iracema Nayach

Since Specialization
Citations

This map shows the geographic impact of Iracema Nayach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iracema Nayach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iracema Nayach more than expected).

Fields of papers citing papers by Iracema Nayach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iracema Nayach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iracema Nayach. The network helps show where Iracema Nayach may publish in the future.

Co-authorship network of co-authors of Iracema Nayach

This figure shows the co-authorship network connecting the top 25 collaborators of Iracema Nayach. A scholar is included among the top collaborators of Iracema Nayach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iracema Nayach. Iracema Nayach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 8
2 14
3 56
4 12
5 110
6 74
7 57
8 1
9 238
10
Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
53
11 76
12
PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
216

About Iracema Nayach

Iracema Nayach is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 12 papers that have together received 915 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Cancer-related Molecular Pathways (4 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (438 citations), Genetics (222 citations) and Oncology (544 citations). Iracema Nayach has collaborated with scholars based in Spain, Netherlands and France. Frequent co-authors include Elı́as Campo, Pedro L. Fernández, Pedro Jares, Magda Pinyol, Antonio Cardesa, Sı́lvia Beà, Emilio Montserrat, Francesc Bosch, Alfons Nadal and Francesc Cobo. Their work appears in journals such as Blood, American Journal Of Pathology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026